Maya Margalit

1.7k citations
46 papers · 1.1k indexed · 1 hit paper · h-index 17

Impact in

  • Hepatology top 5%
  • Immunology top 10%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology

Papers in

    • Liver Disease Diagnosis and Treatment 16
    • Immune Cell Function and Interaction 12
    • T-cell and B-cell Immunology 8

Maya Margalit

43 papers receiving 1.1k citations

Hit Papers

Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH 2023 · 271 citations
271202320262024202550100150200250

Peers

Maya Margalit
Comparison fields: 5 of 80
  • Hepatology 123
  • Immunology 317
  • Epidemiology 508
  • Endocrinology, Diabetes and Metabolism 212
  • Cell Biology 107
Replace Daniel A. Giles with:
Daniel A. Giles United States
Nadine Gehrke Germany
Tomer Adar Israel
Kotaro Kumagai Japan
M Köllinger Germany
Zengyan Wang China
Shiyun Tan China
Yanhang Gao China
Traci E. Stankiewicz United States
Mounzer Soued United States
Maya Margalit relative to Daniel A. Giles United States Daniel A. Giles's profile →
Citations per field
00.5×4.5×
Daniel A. Giles · 1×
Citations per year

Countries citing papers authored by Maya Margalit

Since Specialization
Citations

This map shows the geographic impact of Maya Margalit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Margalit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Margalit more than expected).

Fields of papers citing papers by Maya Margalit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya Margalit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Margalit. The network helps show where Maya Margalit may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maya Margalit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maya Margalit Line = papers co-authored together Maya Margalit links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20240
3 20240
4 20238
5 20231
6 202316
7
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
Hit paper breakdown →
2023271
8 202272
9 20204
10 20201
11 200735
12 200681
13 200693
14 200542
15 200516
16 200534
17 200562
18 20047
19 200335
20 200125

About Maya Margalit

Maya Margalit is a scholar working on Epidemiology, Immunology, Complementary and Manual Therapy, Hepatology and Hematology, having authored 46 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (16 papers), Fibroblast Growth Factor Research (14 papers), Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (8 papers), Pancreatitis Pathology and Treatment (5 papers), Diet, Metabolism, and Disease (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Hepatology (123 citations), Immunology (317 citations), Epidemiology (508 citations), Endocrinology, Diabetes and Metabolism (212 citations) and Cell Biology (107 citations). Maya Margalit has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Yaron Ilan, Elazar Rabbani, Dean Engelhardt, Orit Pappo, Hank Mansbach, Rohit Loomba, R. Alper, Juan P. Frías, Barbara Thalenfeld and Eran Elinav. Their work appears in journals such as Journal of Hepatology, Hepatology, Metabolism, Journal of Pharmacology and Experimental Therapeutics and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026